Sustainability Report

Overview

The report, Cumberland Pharmaceuticals' inaugural ESG disclosure, highlights a workforce that was 48% women and reports no work-related injuries in 2018-2019. It describes product-safety controls, including no recalls and no products listed in FDA safety alerts during 2019. The company also covered 98% of patient costs for gastrointestinal products and donated over $30,000 to nonprofit organizations in 2019.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2019
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services